Related Experiment Video

Updated: Jul 3, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Chk2 suppresses the oncogenic potential of DNA replication-associated DNA damage

Travis H Stracker1, Suzana S Couto, Carlos Cordon-Cardo

  • 1Molecular Biology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, Cornell University Graduate School of Medical Sciences, New York, NY 10021, USA.

Molecular Cell
|July 11, 2008
PubMed

Insights

The Mre11 complex and Chk2 protein are crucial for DNA damage response. Their combined deficiency synergistically impairs DNA repair and p53 regulation, increasing tumor predisposition.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Background:

  • The Mre11 complex (Mre11, Rad50, Nbs1) and Chk2 kinase are key players in the DNA-damage response, essential for preventing cancer.
  • The Mre11 complex primarily handles DNA repair and checkpoint activation during S phase, while Chk2 regulates apoptosis.

Purpose of the Study:

  • To investigate the functional relationship between the Mre11 complex and Chk2 in the DNA-damage response.
  • To determine if combined deficiencies in these proteins lead to synergistic defects and increased oncogenic potential.

Main Methods:

  • Generation and analysis of Nbs1(DeltaB/DeltaB) Chk2(-/-) and Mre11(ATLD1/ATLD1) Chk2(-/-) double-mutant mice.
  • Assessment of DNA-damage-induced checkpoint activation, chromosomal instability, p53 regulation, and apoptosis.
  • Comparison with DNA-PKcs-deficient Chk2(-/-) double mutants.

Main Results:

  • Chk2 deficiency did not exacerbate the checkpoint defects or chromosomal instability in Mre11 complex mutants.
  • Double-mutant mice (Nbs1(DeltaB/DeltaB) Chk2(-/-) and Mre11(ATLD1/ATLD1) Chk2(-/-)) showed synergistic defects in DNA-damage-induced p53 regulation and apoptosis.
  • These double mutants exhibited increased predisposition to tumor development.
  • In contrast, DNA-PKcs deficiency did not show synergistic effects with Chk2 deficiency.

Conclusions:

  • Chk2 acts to suppress the oncogenic potential of DNA damage that occurs during the S and G2 phases of the cell cycle.
  • The interplay between the Mre11 complex and Chk2 is critical for preventing malignancy following DNA damage in specific cell cycle phases.

More Related Videos

Detection of DNA Breaks in Dividing Human Cells by Neutral Comet Assay05:55

Detection of DNA Breaks in Dividing Human Cells by Neutral Comet Assay

Published on: August 23, 2024

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.